These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37352379)

  • 21. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
    Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
    Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
    Qin JZ; Upadhyay V; Prabhakar B; Maker AV
    J Transl Med; 2013 Mar; 11():70. PubMed ID: 23514280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
    Yan Y; Zheng L; Du Q; Yazdani H; Dong K; Guo Y; Geller DA
    Cancer Lett; 2021 May; 506():95-106. PubMed ID: 33689775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
    Chen W; Chen X; Li S; Ren B
    J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
    Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.
    Lu C; Rong D; Zhang B; Zheng W; Wang X; Chen Z; Tang W
    Mol Cancer; 2019 Aug; 18(1):130. PubMed ID: 31464625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG
    Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
    Wang W; Wu J; Ji M; Wu C
    J Transl Med; 2020 Dec; 18(1):477. PubMed ID: 33308251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma.
    Rohr-Udilova N; Klinglmüller F; Schulte-Hermann R; Stift J; Herac M; Salzmann M; Finotello F; Timelthaler G; Oberhuber G; Pinter M; Reiberger T; Jensen-Jarolim E; Eferl R; Trauner M
    Sci Rep; 2018 Apr; 8(1):6220. PubMed ID: 29670256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.
    Zhao S; Mi Y; Guan B; Zheng B; Wei P; Gu Y; Zhang Z; Cai S; Xu Y; Li X; He X; Zhong X; Li G; Chen Z; Li D
    J Hematol Oncol; 2020 Nov; 13(1):156. PubMed ID: 33213490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
    Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
    Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.
    Zhao N; Dang H; Ma L; Martin SP; Forgues M; Ylaya K; Hewitt SM; Wang XW
    Hepatology; 2021 Mar; 73(3):1045-1060. PubMed ID: 32502310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
    Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
    Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma.
    Chen DP; Ning WR; Li XF; Wei Y; Lao XM; Wang JC; Wu Y; Zheng L
    Autophagy; 2018; 14(8):1335-1346. PubMed ID: 29940792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment.
    Zhao S; Mi Y; Zheng B; Wei P; Gu Y; Zhang Z; Xu Y; Cai S; Li X; Li D
    J Extracell Vesicles; 2022 Jan; 11(1):e12186. PubMed ID: 35041299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.